The Responsible Biotics Framework™
The Responsible Biotics Framework™
A science-to-market reliability framework for microbiome-directed products in human and animal health.
Biotics are moving from promising science to commercial products at remarkable speed.
The difficult part is not only finding an interesting organism, ingredient, or microbiome effect. The difficult part is making sure that the product we define, the evidence we generate, the claims we make, and the product that reaches the user still belong to the same scientific story.
The Responsible Biotics Framework™ provides a structured approach for developing, evaluating, and maintaining biotic and microbiome-directed products across their lifecycle.
It is built around six questions:
Do we know what it is?
Is it safe?
Does the evidence support the intended benefit?
Can we responsibly make the claim?
Can we consistently deliver the product?
Will we continue to stand behind it after launch?
THE SIX GATES
Identity & Characterization
Know what it is.
Clearly identify the product, its composition, active components, potency, purity, and traceability.
Safety & Risk Stewardship
Know what could go wrong.
Assess safety risks based on the product, dose, use, target population, and potential One Health impacts.
Target-Host Benefit & Biological Rationale
Show that it works.
Evidence should demonstrate the claimed benefit in the intended species, population, and conditions of use.
Regulatory Pathway & Claims Discipline
Know what you can legally claim.
Define the correct regulatory pathway and ensure all product claims are scientifically and legally supportable.
Product & Process Integrity
Deliver what the evidence supports.
Ensure manufacturing, formulation, storage, and quality controls consistently deliver the product that was actually studied.
Lifecycle Accountability
Keep evaluating after launch.
Monitor safety, quality, performance, changes, complaints, and new evidence throughout the product’s lifecycle.
Product-Evidence-Claim Concordance
The commercial product, the supporting evidence, the intended use, and the claim must remain scientifically connected.
Evidence is most reliable when it applies to the same or sufficiently comparable:
-
active organism, ingredient, or preparation
-
strain or microbial composition, when relevant
-
dose
-
formulation
-
route
-
target host or population
-
conditions of use
-
intended benefit
A material change can break this connection.
That is why a change in the strain, ingredient, supplier, formulation, process, dose, target population, intended use, or claim should trigger scientific reassessment.
WHERE THE FRAMEWORK APPLIES
The core framework is designed for:
Its principles can also support the assessment of other microbiome-directed technologies when scientifically appropriate, including microbial consortia, live biotherapeutic products, bacteriophages, fermented preparations, microbial metabolites, and other emerging microbiome technologies.
The framework does not assume that every microbiome-related ingredient qualifies as a biotic.
Scientific terminology must be earned.
A fiber is not automatically a prebiotic.
A microorganism is not automatically a probiotic.
An inactivated microorganism is not automatically a postbiotic.
WHERE THE FRAMEWORK APPLIES
The Responsible Biotics Framework™ was developed by Sigma BioVet Sciences LLC under the scientific direction of Nihan Marun, DVM, PhD, drawing on experience across microbiology, probiotics and microbiome science, animal health, product development, regulatory strategy, manufacturing, and scientific evaluation.
